Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CELLDEX THERAPEUTICS INC NEW
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 120,807 shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $3.8M as of 2026-Q1. The position was increased (+2.7% shares). CLDX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.8M
Current Shares
120,807
Total Value Change
+$266,972
Total Shares Change
+24,481
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP
Increased |
| 120,807 |
+2.7% |
| $3.8M |
| 0.0% |
| $28.94 |
27 |
| 2025-Q4 | Increased | 117,589 | +11.5% | $3.2M | 0.0% | $26.43 | 29 |
| 2025-Q3 | Decreased | 105,478 | -50.7% | $2.7M | 0.0% | $26.19 | 0 |
| 2025-Q2 | Increased | 213,846 | +62.9% | $4.4M | 0.0% | $20.29 | 39 |
| 2025-Q1 | Increased | 131,296 | +12.9% | $2.4M | 0.0% | $19.93 | 29 |
| 2024-Q4 | Increased | 116,317 | +13.4% | $2.9M | 0.0% | $25.12 | 30 |
| 2024-Q3 | Increased | 102,595 | +6.5% | $3.5M | 0.0% | $33.20 | 28 |
| 2024-Q2 | Increased | 96,326 | +148.8% | $3.6M | 0.0% | $37.01 | 43 |